Skip to main content
Top
Published in: Comparative Clinical Pathology 5/2013

01-09-2013 | Original Article

TNF-α-308 promoter G/A and PTPN22 (1858 C/T) genes polymorphisms in Egyptian patients with systemic lupus erythematosus

Authors: Mona Mohamad Fathy, Manal Mohamad Kamal, Fatma El-Mougy, Tamer Gheita, Asmaa Kamal

Published in: Comparative Clinical Pathology | Issue 5/2013

Login to get access

Abstract

Tumor necrosis factor alpha (TNF-α) promoter gene polymorphism at position 308 and that of the protein tyrosine phosphatase nonreceptor type 22 (PTPN22) at position 1858 C/T have been inconsistently implicated as genetic risk factors for systemic lupus erythematosus (SLE) in some populations. We investigated the possible association of these polymorphisms with SLE susceptibility, and whether serum TNF-α level is related to different genotypes and disease activity in Egyptian SLE patients. TNF-α-308 G/A and PTPN22 C1858T polymorphisms were determined by PCR-restriction fragment length polymorphism analysis in 40 SLE patients and 40 unrelated healthy controls. Serum TNF-α level was measured by ELISA method. The median serum TNF-α was significantly higher in SLE patients than in controls (P < 0.001). A significant positive correlation was detected between serum TNF-α and SLE activity index (r = 0.723, P < 0.001). There was no significant difference in TNF-α-308 G/A genotypes or allele frequency between SLE cases and controls (P = 0.108 and P = 0.133, respectively). Diabetes was the only clinical feature in SLE patients that showed significant higher frequency with GA genotype than with GG genotype (P = 0.001). Risk estimation for the TNF-α-308 genotypes was of no significant (odds ratio = 2.429; 95 % CI = 0.8–7.2; P = 0.108). Concerning PTPN22 1858 C/T, there was no significant difference in PTPN22 C/T genotypes or allele frequency between SLE cases and controls (P = 0.152 and P = 0.155, respectively). TNF-α-308 G/A and PTPN22 (1858 C/T) polymorphisms do not exhibit a significant influence on the susceptibility of SLE in Egyptian patients. However, serum TNF-α level could be a sensitive marker of SLE disease activity.
Literature
go back to reference Aksoy R, Duman T, Keskin O, Düzgün N (2011) No association of PTPN22 R620 W gene polymorphism with rheumatic heart disease and systemic lupus erythematosus. Mol Biol Rep 38(8):5393–5396PubMedCrossRef Aksoy R, Duman T, Keskin O, Düzgün N (2011) No association of PTPN22 R620 W gene polymorphism with rheumatic heart disease and systemic lupus erythematosus. Mol Biol Rep 38(8):5393–5396PubMedCrossRef
go back to reference Al-Mutairi S, Al-Awadhi A, Raghupathy et al (2007) Lupus patients with pulmonary involvement have a pro-inflammatory cytokines profile. Rheumatol Int 27:621–630PubMedCrossRef Al-Mutairi S, Al-Awadhi A, Raghupathy et al (2007) Lupus patients with pulmonary involvement have a pro-inflammatory cytokines profile. Rheumatol Int 27:621–630PubMedCrossRef
go back to reference Azizah MR, Kuak SH, Ainol SS, Rahim MN, Normaznah Y, Norella K (2004) Association of TNF-α promoter gene polymorphism with susceptibility and clinical-immunological findings of SLE. Asian Pacific Journal of Allergy and Immunology 22:159–163PubMed Azizah MR, Kuak SH, Ainol SS, Rahim MN, Normaznah Y, Norella K (2004) Association of TNF-α promoter gene polymorphism with susceptibility and clinical-immunological findings of SLE. Asian Pacific Journal of Allergy and Immunology 22:159–163PubMed
go back to reference D'Alfonso S, Colombo G, Della Bella S, Scorza R, Momigliano-Richiardi P (1996) Association between polymorphisms in the TNF region and systemic lupus erythematosus in the Italian population. Tissue Antigens 47:551–555PubMedCrossRef D'Alfonso S, Colombo G, Della Bella S, Scorza R, Momigliano-Richiardi P (1996) Association between polymorphisms in the TNF region and systemic lupus erythematosus in the Italian population. Tissue Antigens 47:551–555PubMedCrossRef
go back to reference Eliopoulos E, Zervou MI, Andreou A, Dimopoulou K, Cosmidis N, Voloudakis G, Mysirlaki H, Vazgiourakis V, Sidiropoulos P, Niewold TB, Boumpas DT, Goulielmos GN (2011) Association of the PTPN22 R620W polymorphism with increased risk for SLE in the genetically homogeneous population of Crete. Lupus 20(5):501–506PubMedCrossRef Eliopoulos E, Zervou MI, Andreou A, Dimopoulou K, Cosmidis N, Voloudakis G, Mysirlaki H, Vazgiourakis V, Sidiropoulos P, Niewold TB, Boumpas DT, Goulielmos GN (2011) Association of the PTPN22 R620W polymorphism with increased risk for SLE in the genetically homogeneous population of Crete. Lupus 20(5):501–506PubMedCrossRef
go back to reference Esposito P, Balletta MM, Procino A, Postiglione L, Memoli B (2009) Interleukin-6 release from peripheral mononuclear cells is associated to disease activity and treatment response in patients with lupus nephritis. Lupus 18(14):1329–1330 Esposito P, Balletta MM, Procino A, Postiglione L, Memoli B (2009) Interleukin-6 release from peripheral mononuclear cells is associated to disease activity and treatment response in patients with lupus nephritis. Lupus 18(14):1329–1330
go back to reference Fugger L, Morling N, Ryder LP, Georgsen J, Jakobsen BK, Svejgaard A et al (1989) NcoI restriction fragment length polymorphism (RFLP) of the tumor necrosis factor (TNF alpha) region in four autoimmune diseases. Tissue Antigens 34:17–22PubMedCrossRef Fugger L, Morling N, Ryder LP, Georgsen J, Jakobsen BK, Svejgaard A et al (1989) NcoI restriction fragment length polymorphism (RFLP) of the tumor necrosis factor (TNF alpha) region in four autoimmune diseases. Tissue Antigens 34:17–22PubMedCrossRef
go back to reference Gabay C, Cakir N, Moral F, Roux-Lombard P, Meyer O, Dayer JM et al (1997) Circulating levels of tumor necrosis factor soluble receptors in systemic lupus erythematosus are significantly higher than in other rheumatic diseases and correlate with disease activity. J Rheumatol 24:303–308PubMed Gabay C, Cakir N, Moral F, Roux-Lombard P, Meyer O, Dayer JM et al (1997) Circulating levels of tumor necrosis factor soluble receptors in systemic lupus erythematosus are significantly higher than in other rheumatic diseases and correlate with disease activity. J Rheumatol 24:303–308PubMed
go back to reference Garnacho MJ, Aldabo PT, Garnacho MC, Cayuela A, Jiménez R, Barroso S, Ortiz-Leyba C (2006) Timing of adequate antibiotic therapy is a greater determinant of outcome than are TNF and IL-10 polymorphisms in patients with sepsis. Crit Care 10(4):111CrossRef Garnacho MJ, Aldabo PT, Garnacho MC, Cayuela A, Jiménez R, Barroso S, Ortiz-Leyba C (2006) Timing of adequate antibiotic therapy is a greater determinant of outcome than are TNF and IL-10 polymorphisms in patients with sepsis. Crit Care 10(4):111CrossRef
go back to reference Gomez LM, Anaya JM, Gonzalez CI, Pineda-Tamayo R, Otero W, Arango A, Martín J (2005) PTPN22 C1858T polymorphism in Colombian patients with autoimmune diseases. Genes and Immunity 6:628–631PubMedCrossRef Gomez LM, Anaya JM, Gonzalez CI, Pineda-Tamayo R, Otero W, Arango A, Martín J (2005) PTPN22 C1858T polymorphism in Colombian patients with autoimmune diseases. Genes and Immunity 6:628–631PubMedCrossRef
go back to reference Goronzy JJ, Weyand CM (2004) T-cell regulation in rheumatoid arthritis. Curr Opin Rheumatol 16:212–217PubMedCrossRef Goronzy JJ, Weyand CM (2004) T-cell regulation in rheumatoid arthritis. Curr Opin Rheumatol 16:212–217PubMedCrossRef
go back to reference Gregersen PK, Lee HS, Batliwalla F, Begovich AB (2006) PTPN22: setting thresholds for autoimmunity. Semin Immunol 18(4):214–223PubMedCrossRef Gregersen PK, Lee HS, Batliwalla F, Begovich AB (2006) PTPN22: setting thresholds for autoimmunity. Semin Immunol 18(4):214–223PubMedCrossRef
go back to reference Guarnizo ZP, Lopez Y, Giraldo M, Garcia N, Rodriguez L, Ramirez L, Uribe O, Garcia L, Vasquez G (2007) Cytokine gene polymorphisms in Colombian patients with systemic lupus erythematosus. Tissue Antigens 70(5):376–382CrossRef Guarnizo ZP, Lopez Y, Giraldo M, Garcia N, Rodriguez L, Ramirez L, Uribe O, Garcia L, Vasquez G (2007) Cytokine gene polymorphisms in Colombian patients with systemic lupus erythematosus. Tissue Antigens 70(5):376–382CrossRef
go back to reference Hirankarn N, Avihingsanon Y, Wongpiyabovorn J (2007) Genetic susceptibility to SLE is associated with TNF-alpha gene polymorphism −863, but not −308 and −238, in Thai population. Int J Immunogenet 34(6):425–430PubMedCrossRef Hirankarn N, Avihingsanon Y, Wongpiyabovorn J (2007) Genetic susceptibility to SLE is associated with TNF-alpha gene polymorphism −863, but not −308 and −238, in Thai population. Int J Immunogenet 34(6):425–430PubMedCrossRef
go back to reference Jawaheer D, Seldin MF, Amos CI, Chen WV, Shigeta R, Etzel C et al (2003) Screening the genome for rheumatoid arthritis susceptibility genes: a replication study and combined analysis of 512 multicase families. Arthritis Rheum 48:906–916PubMedCrossRef Jawaheer D, Seldin MF, Amos CI, Chen WV, Shigeta R, Etzel C et al (2003) Screening the genome for rheumatoid arthritis susceptibility genes: a replication study and combined analysis of 512 multicase families. Arthritis Rheum 48:906–916PubMedCrossRef
go back to reference Kyogoku C, Langefeld CD, Ortmann WA, Lee A, Selby S, Carlton VE, Chang M, Ramos P, Baechler EC, Batliwalla FM, Novitzke J, Williams AH, Gillett C et al (2004) Genetic association of the R620W polymorphism of protein tyrosine phosphatase PTPN22 with human SLE. Am J Hum Genet 75:504–507PubMedCrossRef Kyogoku C, Langefeld CD, Ortmann WA, Lee A, Selby S, Carlton VE, Chang M, Ramos P, Baechler EC, Batliwalla FM, Novitzke J, Williams AH, Gillett C et al (2004) Genetic association of the R620W polymorphism of protein tyrosine phosphatase PTPN22 with human SLE. Am J Hum Genet 75:504–507PubMedCrossRef
go back to reference Lee YH, Harley JB, Nath SK (2006) Meta-analysis of TNF-alpha promoter −308 A/G polymorphism and SLE susceptibility. Eur J Hum Genet 14:364–371PubMedCrossRef Lee YH, Harley JB, Nath SK (2006) Meta-analysis of TNF-alpha promoter −308 A/G polymorphism and SLE susceptibility. Eur J Hum Genet 14:364–371PubMedCrossRef
go back to reference Lin YJ, Chen RH, Wan L, Sheu JC et al (2009) Association of TNF-alpha gene polymorphisms with systemic lupus erythematosus in Taiwanese patients. Lupus 18:974–979PubMedCrossRef Lin YJ, Chen RH, Wan L, Sheu JC et al (2009) Association of TNF-alpha gene polymorphisms with systemic lupus erythematosus in Taiwanese patients. Lupus 18:974–979PubMedCrossRef
go back to reference Mahmoud RA, El-Gendi HI, Ahmed HH (2005) Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus. Clin Biochem 38(2):134–141PubMedCrossRef Mahmoud RA, El-Gendi HI, Ahmed HH (2005) Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus. Clin Biochem 38(2):134–141PubMedCrossRef
go back to reference Mosca M, Bombardieri S (2006) Assessing remission in systemic lupus erythematosus. Clin Exp Rheumatol 24(43):100–104 Mosca M, Bombardieri S (2006) Assessing remission in systemic lupus erythematosus. Clin Exp Rheumatol 24(43):100–104
go back to reference Orozco G, Sánchez E, González-Gay MA, López-Nevot MA, Torres B, Cáliz R et al (2005) Association of a functional single-nucleotide polymorphism of PTPN22, encoding lymphoid protein phosphatase, with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Rheum 52(1):219–224PubMedCrossRef Orozco G, Sánchez E, González-Gay MA, López-Nevot MA, Torres B, Cáliz R et al (2005) Association of a functional single-nucleotide polymorphism of PTPN22, encoding lymphoid protein phosphatase, with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Rheum 52(1):219–224PubMedCrossRef
go back to reference Parks CG, Pandey JP, Dooley MA, Treadwell EL, St Clair EW, Gilkeson GS et al (2004) Genetic polymorphisms in tumor necrosis factor (TNF)-alpha and TNF-beta in a population-based study of systemic lupus erythematosus: associations and interaction with the interleukin-1alpha-889 C/T polymorphism. Hum Immunol 65:622–631PubMedCrossRef Parks CG, Pandey JP, Dooley MA, Treadwell EL, St Clair EW, Gilkeson GS et al (2004) Genetic polymorphisms in tumor necrosis factor (TNF)-alpha and TNF-beta in a population-based study of systemic lupus erythematosus: associations and interaction with the interleukin-1alpha-889 C/T polymorphism. Hum Immunol 65:622–631PubMedCrossRef
go back to reference Pradhan V, Borse V, Ghosh K (2010) PTPN22 gene polymorphisms in autoimmune diseases with special reference to systemic lupus erythematosus disease susceptibility. J Postgrad Med 56(3):239–242PubMedCrossRef Pradhan V, Borse V, Ghosh K (2010) PTPN22 gene polymorphisms in autoimmune diseases with special reference to systemic lupus erythematosus disease susceptibility. J Postgrad Med 56(3):239–242PubMedCrossRef
go back to reference Reddy MV, Johansson M, Sturfelt G, Jönsen A, Gunnarsson I, Svenungsson E et al (2005) The R620W C/T polymorphism of the gene PTPN22 is associated with SLE independently of the association of PDCD1. Genes Immun 6:658–662PubMed Reddy MV, Johansson M, Sturfelt G, Jönsen A, Gunnarsson I, Svenungsson E et al (2005) The R620W C/T polymorphism of the gene PTPN22 is associated with SLE independently of the association of PDCD1. Genes Immun 6:658–662PubMed
go back to reference Rudwaleit M, Tikly M, Khamashta M, Gibson K, Klinke J, Hughes G et al (1996) Interethnic differences in the association of tumor necrosis factor promoter polymorphisms with systemic lupus erythematosus. J Rheumatol 23:1725–1728PubMed Rudwaleit M, Tikly M, Khamashta M, Gibson K, Klinke J, Hughes G et al (1996) Interethnic differences in the association of tumor necrosis factor promoter polymorphisms with systemic lupus erythematosus. J Rheumatol 23:1725–1728PubMed
go back to reference Sabry A, Sheashaa H, El-Husseini A, Mahmoud K, Eldahshan KF, George SK, Abdel-Khalek E, El-Shafey EM, Abo-Zenah H (2006) Proinflammatory cytokines (TNF-alpha and IL-6) in Egyptian patients with SLE: its correlation with disease activity. Cytokine 35:148–153PubMedCrossRef Sabry A, Sheashaa H, El-Husseini A, Mahmoud K, Eldahshan KF, George SK, Abdel-Khalek E, El-Shafey EM, Abo-Zenah H (2006) Proinflammatory cytokines (TNF-alpha and IL-6) in Egyptian patients with SLE: its correlation with disease activity. Cytokine 35:148–153PubMedCrossRef
go back to reference Santos MJ, Carmona-Fernandes D, Caetano-Lopes J, Perpétuo IP, Vidal B, Capela S et al (2011) TNF promoter −308 G > A and LTA 252 A > G polymorphisms in Portuguese patients with systemic lupus erythematosus. Rheumatol Int Clin Exp Invest 10:1950–1957 Santos MJ, Carmona-Fernandes D, Caetano-Lopes J, Perpétuo IP, Vidal B, Capela S et al (2011) TNF promoter −308 G > A and LTA 252 A > G polymorphisms in Portuguese patients with systemic lupus erythematosus. Rheumatol Int Clin Exp Invest 10:1950–1957
go back to reference Serrano NC, Millan P, Paez MC (2006) Non-HLA associations with autoimmune diseases. Autoimmun Rev 5:209–214PubMedCrossRef Serrano NC, Millan P, Paez MC (2006) Non-HLA associations with autoimmune diseases. Autoimmun Rev 5:209–214PubMedCrossRef
go back to reference Steck AK, Liu SY, McFann K, Barriga KJ, Babu SR, Eisenbarth GS, Rewers MJ, She JX (2006) Association of the PTPN22/LYP gene with type 1 diabetes. Pediatr Diabetes 7:274–278PubMedCrossRef Steck AK, Liu SY, McFann K, Barriga KJ, Babu SR, Eisenbarth GS, Rewers MJ, She JX (2006) Association of the PTPN22/LYP gene with type 1 diabetes. Pediatr Diabetes 7:274–278PubMedCrossRef
go back to reference Takeuchi F, Nakano K, Nabeta H, Hong GH, Kawasugi K, Mori M et al (2005) Genetic contribution of the tumour necrosis factor (TNF) B + 252*2/2 genotype, but not the TNFa, b microsatellite alleles, to systemic lupus erythematosus in Japanese patients. Int J Immunogenet 32:173–178PubMedCrossRef Takeuchi F, Nakano K, Nabeta H, Hong GH, Kawasugi K, Mori M et al (2005) Genetic contribution of the tumour necrosis factor (TNF) B + 252*2/2 genotype, but not the TNFa, b microsatellite alleles, to systemic lupus erythematosus in Japanese patients. Int J Immunogenet 32:173–178PubMedCrossRef
go back to reference Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF et al (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277PubMedCrossRef Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF et al (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277PubMedCrossRef
go back to reference Tobón GJ, Correa PA, Gomez LM, Anaya JM (2005) Lack of association between TNF-308 polymorphism and the clinical and immunological characteristics of systemic lupus erythematosus and primary Sjögren's syndrome. Clin Exp Rheumatol 23(3):339–344PubMed Tobón GJ, Correa PA, Gomez LM, Anaya JM (2005) Lack of association between TNF-308 polymorphism and the clinical and immunological characteristics of systemic lupus erythematosus and primary Sjögren's syndrome. Clin Exp Rheumatol 23(3):339–344PubMed
go back to reference Viken MK, Amundsen SS, Kvien TK, Boberg KM, Gilboe IM, Lilleby V, Sollid LM, Forre OT, Thorsby E, Smerdel A, Lie BA (2005) Association analysis of the 1858 C > T polymorphism in the PTPN22 gene in juvenile idiopathic arthritis and other autoimmune diseases. Genes Immun 6:271–273PubMedCrossRef Viken MK, Amundsen SS, Kvien TK, Boberg KM, Gilboe IM, Lilleby V, Sollid LM, Forre OT, Thorsby E, Smerdel A, Lie BA (2005) Association analysis of the 1858 C > T polymorphism in the PTPN22 gene in juvenile idiopathic arthritis and other autoimmune diseases. Genes Immun 6:271–273PubMedCrossRef
go back to reference Wu H, Cantor RM, Graham DS, Lingren CM, Farwell L, Jager PL, Bottini N, Grossman JM, Wallace DJ, Hahn BH, Julkunen H, Hebert LA, Rovin BH et al (2005) Association analysis of the R620W polymorphism of protein tyrosine phosphatase PTPN22 in systemic lupus erythematosus families: increased T allele frequency in systemic lupus erythematosus patients with autoimmune thyroid disease. Arthritis Rheum 52:2396–2402PubMedCrossRef Wu H, Cantor RM, Graham DS, Lingren CM, Farwell L, Jager PL, Bottini N, Grossman JM, Wallace DJ, Hahn BH, Julkunen H, Hebert LA, Rovin BH et al (2005) Association analysis of the R620W polymorphism of protein tyrosine phosphatase PTPN22 in systemic lupus erythematosus families: increased T allele frequency in systemic lupus erythematosus patients with autoimmune thyroid disease. Arthritis Rheum 52:2396–2402PubMedCrossRef
go back to reference Zou YF, Feng XL, Tao JH, Su H, Pan FM, Liao FF, Ye F, Ye DQ (2010) Meta-analysis of TNF-α promoter -308A/G polymorphism and SLE susceptibility in Asian populations. Rheumatol Int 31(8):1055–1064PubMedCrossRef Zou YF, Feng XL, Tao JH, Su H, Pan FM, Liao FF, Ye F, Ye DQ (2010) Meta-analysis of TNF-α promoter -308A/G polymorphism and SLE susceptibility in Asian populations. Rheumatol Int 31(8):1055–1064PubMedCrossRef
go back to reference Zúñiga J, Vargas-Alarcón G, Hernández-Pacheco G, Portal-Celhay C, Yamamoto-Furusho JK, Granados J (2001) Tumor necrosis factor-alpha promoter polymorphisms in Mexican patients with systemic lupus erythematosus (SLE). Genes Immun 2:363–366PubMedCrossRef Zúñiga J, Vargas-Alarcón G, Hernández-Pacheco G, Portal-Celhay C, Yamamoto-Furusho JK, Granados J (2001) Tumor necrosis factor-alpha promoter polymorphisms in Mexican patients with systemic lupus erythematosus (SLE). Genes Immun 2:363–366PubMedCrossRef
Metadata
Title
TNF-α-308 promoter G/A and PTPN22 (1858 C/T) genes polymorphisms in Egyptian patients with systemic lupus erythematosus
Authors
Mona Mohamad Fathy
Manal Mohamad Kamal
Fatma El-Mougy
Tamer Gheita
Asmaa Kamal
Publication date
01-09-2013
Publisher
Springer London
Published in
Comparative Clinical Pathology / Issue 5/2013
Print ISSN: 1618-5641
Electronic ISSN: 1618-565X
DOI
https://doi.org/10.1007/s00580-012-1506-6

Other articles of this Issue 5/2013

Comparative Clinical Pathology 5/2013 Go to the issue